ATE328888T1 - Radicicol und monocillin und ihre analogen und ihre anwendungen - Google Patents

Radicicol und monocillin und ihre analogen und ihre anwendungen

Info

Publication number
ATE328888T1
ATE328888T1 AT01966236T AT01966236T ATE328888T1 AT E328888 T1 ATE328888 T1 AT E328888T1 AT 01966236 T AT01966236 T AT 01966236T AT 01966236 T AT01966236 T AT 01966236T AT E328888 T1 ATE328888 T1 AT E328888T1
Authority
AT
Austria
Prior art keywords
monocillin
radicicol
analogues
applications
sub
Prior art date
Application number
AT01966236T
Other languages
English (en)
Inventor
Samuel J Danishefsky
Robert M Garbaccio
Daniel K Baeschlin
Shawn J Stachel
David Solit
Neil Rosen
Original Assignee
Sloan Kettering Inst Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Inst Cancer filed Critical Sloan Kettering Inst Cancer
Application granted granted Critical
Publication of ATE328888T1 publication Critical patent/ATE328888T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D225/00Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Circuits Of Receivers In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
AT01966236T 2000-08-25 2001-08-24 Radicicol und monocillin und ihre analogen und ihre anwendungen ATE328888T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22827700P 2000-08-25 2000-08-25
US30455301P 2001-07-11 2001-07-11
US09/938,754 US7115651B2 (en) 2000-08-25 2001-08-24 Macrocycles and uses thereof

Publications (1)

Publication Number Publication Date
ATE328888T1 true ATE328888T1 (de) 2006-06-15

Family

ID=27397829

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01966236T ATE328888T1 (de) 2000-08-25 2001-08-24 Radicicol und monocillin und ihre analogen und ihre anwendungen

Country Status (6)

Country Link
US (1) US7115651B2 (de)
EP (1) EP1315732B1 (de)
AT (1) ATE328888T1 (de)
AU (1) AU2001286768A1 (de)
DE (1) DE60120427D1 (de)
WO (1) WO2002016369A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7705120B2 (en) 2001-06-21 2010-04-27 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
US20050182129A1 (en) * 2002-04-17 2005-08-18 Akiko Ikeda Hair growth tonic
EP1633774B1 (de) 2003-06-18 2010-02-17 Tranzyme Pharma Inc. Makrozyklische motilin rezeptorantagonisten
JP4575294B2 (ja) 2003-06-27 2010-11-04 協和発酵キリン株式会社 Hsp90ファミリー蛋白質阻害剤
US20070004674A1 (en) * 2003-08-22 2007-01-04 Kyowa Hakko Kogyo Co. Ltd. Remedy for diseases associated with immunoglobulin gene translocation
US8329683B2 (en) 2006-06-02 2012-12-11 Nexgenix Pharmaceuticals, Llc Treatment of neurofibromatosis with radicicol and its derivatives
WO2008150302A1 (en) * 2007-06-04 2008-12-11 Nexgenix Pharmaceuticals Treatment of neurofibromatosis with radicicol and its derivatives
WO2008021213A1 (en) * 2006-08-11 2008-02-21 Nicolas Winssinger Macrocyclic compounds useful as inhibitors of kinases and hsp90
AU2008287542C1 (en) 2007-06-01 2015-01-22 The Trustees Of Princeton University Treatment of viral infections by modulation of host cell metabolic pathways
EP2173733A2 (de) * 2007-06-05 2010-04-14 WINSSINGER, Nicolas Zusammensetzungen und verfahren mit analogen von radicicol a
EP2200653A2 (de) * 2007-09-10 2010-06-30 University of Massachusetts Antitumorale mittel gegen mitochondrien
US20110190237A1 (en) * 2008-01-15 2011-08-04 Nexgenix Pharmaceuticals Macrocyclic Prodrug Compounds Useful as Therapeutics
MX2010007755A (es) 2008-01-15 2010-12-21 Univ Strasbourg Sintesis de lactonas de acido resorcilico utiles como agentes terapeuticos.
US20090258869A1 (en) * 2008-02-08 2009-10-15 The Regents Of The University Of California Methods and compounds for treatment or prevention of substance-related disorders
EP2254880B8 (de) 2008-02-21 2016-09-21 OncoSynergy, Inc. Als Therapeutika geeignete makrocyclische Prodrugverbindungen
US8663210B2 (en) 2009-05-13 2014-03-04 Novian Health, Inc. Methods and apparatus for performing interstitial laser therapy and interstitial brachytherapy
WO2016196256A2 (en) 2015-06-04 2016-12-08 University Of North Carolina At Greensboro Non-aromatic difluoro analogues of resorcylic acid lactones
PT3658148T (pt) 2017-07-28 2024-08-26 Turning Point Therapeutics Inc Compostos macrocíclicos e utilizações dos mesmos
US20230390416A1 (en) * 2020-10-16 2023-12-07 The Brigham And Women's Hospital, Inc. Compositions for inducing tumor immunity and reducing drug tolerance

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR96046E (fr) * 1966-06-29 1972-05-19 Commercial Solvents Corp Composé utilisable comme supplément alimentaire pour les animaux.
FR96016E (fr) 1966-06-29 1972-05-19 Commercial Solvents Corp Composé utilisable comme supplément alimentaire pour les animaux.
US3621036A (en) * 1969-02-27 1971-11-16 Merck & Co Inc Derivatives of zearalane
BE757083A (fr) * 1970-02-16 1971-03-16 Commercial Solvents Corp Nouveaux produits a activite antibacterienne
BE757082A (fr) * 1970-02-16 1971-03-16 Commercial Solvents Corp Procede de preparation de nouveaux produits a activite antibacterienne
US3901921A (en) * 1972-04-25 1975-08-26 Commercial Solvents Corp Synthesis of zearalanes and related compounds and intermediates useful in the syntheses thereof
US4035504A (en) * 1975-05-12 1977-07-12 Imc Chemical Group, Inc. Method for treating cholesterolemia by administering resorcylic acid lactone derivatives
US4088658A (en) * 1976-11-04 1978-05-09 Imc Chemical Group, Inc. Synthesis of dideoxyzearalane and related compounds
US4166764A (en) * 1978-02-01 1979-09-04 W. R. Grace & Co. Production of monorden
US4228079A (en) 1978-10-30 1980-10-14 W. R. Grace & Co. Dialkoxy monorden derivatives
IE911915A1 (en) 1990-06-06 1991-12-18 Sankyo Co Radicicol derivatives, their preparation and their¹anti-tumor activity
US5650430A (en) 1990-06-06 1997-07-22 Sankyo Company, Limited Radicicol derivatives, their preparation and their anti-tumor activity
GB9225396D0 (en) 1992-12-04 1993-01-27 Sandoz Ltd Improvements in or relating to organic compounds
US5731343A (en) 1995-02-24 1998-03-24 The Scripps Research Institute Method of use of radicicol for treatment of immunopathological disorders
JP3938936B2 (ja) * 1995-04-26 2007-06-27 協和醗酵工業株式会社 ラディシコール誘導体
JPH09202781A (ja) * 1996-01-25 1997-08-05 Sankyo Co Ltd ラディシコール誘導体
ATE266017T1 (de) 1996-10-25 2004-05-15 Kyowa Hakko Kogyo Kk Radicicolderivate
AU3534499A (en) 1998-04-24 1999-11-16 Kyowa Hakko Kogyo Co. Ltd. Radicicol derivatives
CA2356622A1 (en) * 1998-12-24 2000-07-06 Novation Pharmaceuticals Inc. Compounds which affect mrna stability and uses therefor
WO2000061578A1 (en) 1999-04-09 2000-10-19 Sloan-Kettering Institute For Cancer Research Methods and compositions for degradation and/or inhibition of her-family tyrosine kinases
CA2395136A1 (en) 1999-12-22 2001-06-28 The Scripps Research Institute Angiogenesis and vascular permeability modulators and inhibitors

Also Published As

Publication number Publication date
AU2001286768A1 (en) 2002-03-04
EP1315732B1 (de) 2006-06-07
WO2002016369A3 (en) 2002-08-29
EP1315732A2 (de) 2003-06-04
DE60120427D1 (de) 2006-07-20
US20020091151A1 (en) 2002-07-11
US7115651B2 (en) 2006-10-03
WO2002016369A2 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
ATE328888T1 (de) Radicicol und monocillin und ihre analogen und ihre anwendungen
ATE297203T1 (de) Antithrombotische mitteln
EP1442016A4 (de) 1h-indolderivate als hochselektive cyclooxygenase-2-inhibitoren
CY1108522T1 (el) Μεθοδος συνθεσης της περινδοπριλης και των φαρμακευτικως αποδεκτων αλατων της
SE0302760D0 (sv) New compounds
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
MXPA04004674A (es) Ligados de los receptors de los canabinodies.
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
EA199900937A1 (ru) Фармацевтические композиции, содержащие вориконазол
WO2003053359A3 (en) 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
DE60324544D1 (de) Muskarin antagonisten
SE0101932D0 (sv) Pharmaceutical combinations
BR0105563A (pt) Derivados e análogos de galantamina
SE9901077D0 (sv) Novel use
ATE380174T1 (de) Arginin-mimetika als faktor xa-inhibitoren
ATE272617T1 (de) Sulfonamid-derivate
ATE479657T1 (de) N-(aryl)-2-arylethensulfonamide und ihre therapeutischen anwendungen
CY1108224T1 (el) Καινοτομες κρυσταλλικες μορφες ενος αναστολεα του παραγοντα χα
MXPA03010766A (es) Nuevos compuestos y composiciones como inhibicores de las catepsinas.
SE9801494D0 (sv) Novel use
ATE308540T1 (de) Antithrombosemittel
ATE266029T1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
NO20051282L (no) Antitumorale analoger av lamellariner.
DE60107832D1 (en) Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties